Xtant Medical Holdings
XTNT
18 hedge funds and large institutions have $6.22M invested in Xtant Medical Holdings in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
55% more capital invested
Capital invested by funds: $4.02M → $6.22M (+$2.2M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.58% more ownership
Funds ownership: 92.33% → 92.91% (+0.58%)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$612K |
| 2 |
O
OrbiMed
New York
|
+$93.5K |
| 3 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$54.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$541 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$465 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$127K |
| 2 |
Renaissance Technologies
New York
|
-$23.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3 |
XTNT Hedge Fund Activity: Q3 2022 in Review
18 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2022, worth a combined $6.22M — up 55% from $4.02M a quarter earlier.
Fund positioning in XTNT was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $612K. The largest seller was Bridgeway Capital Management, cutting an estimated $127K.
- 18 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $6.22M of Xtant Medical Holdings stock for Q3 2022, up 55% quarter-over-quarter.
- 3 funds opened new Xtant Medical Holdings positions in Q3 2022 and 3 closed out, a net change of 0 holders.
- The largest Xtant Medical Holdings buyer in Q3 2022 was Vanguard Group, an estimated $612K added.
- The largest Xtant Medical Holdings seller in Q3 2022 was Bridgeway Capital Management, an estimated $127K sold.
Based on aggregated 13F filings for Q3 2022.